SlideShare a Scribd company logo
Dementia –what role 
for prevention? 
Institute of Public Health 
Alzheimer’s Society of Ireland 
Olga Cleary PhD 
IPH Open Conference 14th October 2014
Overview 
• Prevalence 
• Impact 
• Evidence 
• Terminology 
• Dementia protective and risk factors 
• Population attributable risk for 
modifiable factors in Ireland 
• Population approach to dementia 
prevention 
• Process – embedding dementia 
prevention in research, policy and 
practice 
Why? 
What? 
How?
Emergence of 
Neurodegenerative disorders 
Epidemiological transition is underway as a result 
of demographic ageing, characterised by an 
increase in neurodegenerative disorders which will 
gradually come to replace the current burden of 
chronic degenerative disorders as the primary 
cause of morbidity and mortality in the 
21st century!
Dementia prevalence estimates 
• Worldwide - 44 million living with dementia (ADI, 2013) 
• Western Europe - 7 million living with dementia in 
2010 (Prince, 2009) 
• Ireland – 47,744 living with dementia in 2011 (Cahill, and 
Pierce 2013). 
• Expected to double every 20 years 
• By 2031 (if current assumptions hold) estimated to 
be 90,000 people living with dementia in Ireland
Impact 
Care setting Proportion of people 
with dementia 
Community 63% 
Residential Long-stay Care 34% 
Acute Care 2% 
Psychiatric Care 1% 
All 100% 
Connolly et al, 2014 
• €40,500 - average cost per person with dementia per annum 
• €1.69 billion in 2010 
Lowin et al, 2001; Trepel 2012 
• At the individual level, the economic burden of dementia ranks higher 
than stroke, heart disease and cancer combined - allocated resources 
substantially lower than each of these individual disease groups
Question..? 
Resource allocation…………. 
Management 
Treatment 
Diagnosis 
Prevention
Terminology
Alcohol 
Physical 
inactivity 
Coron. heart dis. 
Chron. kidney disease 
Diabetes 
Cholesterol 
Smoking 
Midlife obesity 
High cognitive activity 
Depressed mood 
Healthy diet 
Midlife hypertension 
In-MINDD 
dementia risk 
model
Modelling modifiable dementia risk in Ireland 
Methodology 
- Lancet Neurology 
Barnes and Yaffe (2011) and Norton et al (2014) 
Systematic reviews & meta-analyses – potentially modifiable factors associated with 
increase in Alzheimer’s Disease and cognitive decline (Daviglus et al 2010; McGuiness et al 
2009; Profenno 2010) 
7 Factors with most consistent evidence: 
• Diabetes Mellitus 
• Current smoking 
• Depression 
• Low educational attainment 
• Physical inactivity 
• Obesity 
• Hypertension 
• Poor diet (high sat fat/low veg) 
Calculated PAR based on RRs from Cochrane reviews/meta-analyses 
- Assuming causal relationship between risk factor and disease, PAR is number of cases of a 
disease in a population attributable to the risk factor. 
Irish prevalence estimates taken from Cahill and Pierce (2013) applying EuroCoDe 
dementia prevalence to 2011 census data
Population attributable risk and estimated 
number of attributable cases in Ireland 2011. 
Risk factors TILDA 
weighted 
prevalence 
% 
Relative Risk 
95% CI’s 
PAR 
95% CI’s 
Number of attributable cases 
in 2011 (47,744) 
95% CIs 
Low 
education 
38% 1.59 (1.35-1.86) 18.3% (11.7-24.6) 8,737 (5,586-11,745) 
Obesity 34% 1.6 (1.34-1.92) 16.9% (10.4-23.8) 8,069 (4,965-11,363) 
High Blood 
32% 1.61 (1.16-2.24) 16.5% (4.9-28.7) 7,878 (2,339-13,703) 
Pressure 
Physical 
Inactivity 
32% 1.82 (1.19-2.78) 20.8% (5.7-36.3) 9,930 (2,721-17,331) 
Smoking 20% 1.59 (1.15-2.2) 10.6% (2.9-19.3) 5,060 (1,385-9,215) 
Diabetes 8% 1.46 (1.2-1.77) 3.5% (1.6-5.8) 1,671 (764-2,769) 
Depression 5% 1.65 (1.42-1.92) 3.1% (2.1-4.4) 1,480 (1,003-2,101) 
COMBINED 62.5% (33.6-81.0) 29,840 (16,042-38,673)
Strengths and limitations 
• Estimates based on best available evidence 
• PAR estimates assume a causal relationship between risk factor 
and dementia outcome, however dementia is multi-factorial 
and it is not known if removal/reduction of single risk factors 
will lower incidence 
• Relative risks while robust, are not based on Irish data 
• Risk relations are taken at particular ages and it was not 
possible to model the dynamic interplay of risk factors over the 
lifecycle. 
• Have not adjusted for the non-independence of risk factors 
• May be other important factors influencing risk not accounted 
for in analyses. 
• Community dwelling population in TILDA (excludes 
institutionalised and dementia diagnosed)
Implications of study findings 
• Reductions in prevalence of key modifiable risk factors for dementia is 
likely to lead to a reduction in the onset and prevalence of dementia at 
a population level in Ireland. 
• Estimated combined PAR for Ireland (independent) = 62.5% 
• Pooled methods, accounting for non-independence of the risk factors 
examined, estimated a much more conservative effect (Norton, 2014). 
• Estimated combined PAR for Europe (independent) = 52.7% 
• Estimated pooled combined PAR for Europe (non-independence) = 
30.6% 
• True effect in modifying risk factors remains unknown and we require 
further studies to fully investigate this, but it is likely to lie in the 
magnitude of 30-60% in Ireland. 
• This equates to 14,243 – 28,468 people living with dementia at any one 
time in Ireland. 
• €576,841,500 per annum cost of dementia patients
Developing a population health approach to 
dementia prevention 
• Need to mitigate burden of dementia 
• Moving from: 
• Treatment and management to prevention 
• Clinical concepts to public health 
• Individual focus to population health focus (WHO, 2012) 
• Research to policy and practice 
Older people with better vascular health, who have been more 
physically, mentally and socially active, whose diet is lower in saturated 
fats and higher in vegetable and fruit consumption, who don’t smoke 
and who drink alcohol in moderation are significantly less likely on 
average to develop dementia.
Development of a public health approach to dementia 
prevention that is strategic, evidence-based and 
comprehensive 
(McDaid and McAvoy, 2012 - National Dementia Strategy submission) 
• Potential for public health interventions 
• Synergies in prevention 
• Embed dementia prevention in policy and practice 
• Enhance current DoH and HSE strategies and programmes 
• Afford priority to counteracting risk factors for CVD 
• Appropriate intervention for CVD risk factors and 
preventative health practices in primary care 
• Concept of brain health emerging as an important 
paradigm on the neuroscience and public health agenda 
• Social patterning and early years intervention
Thank You! 
Contact: 
olga.cleary@publichealth.ie 
Acknowledgements: 
Helen McAvoy and Owen Metcalf (Institute of Public Health) 
Margaret Crean, Emer Begley and Grainne McGettrick (Alzheimer’s Society 
of Ireland) 
TILDA team

More Related Content

What's hot

Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
NeurologyKota
 
Drug Resistant Epilepsy
Drug Resistant EpilepsyDrug Resistant Epilepsy
Drug Resistant Epilepsy
Dr. Arun Mathai Mani
 
Dementia updates
Dementia  updates  Dementia  updates
Dementia updates
NeurologyKota
 
Approach to a case of Dementia
Approach to a case of Dementia Approach to a case of Dementia
Approach to a case of Dementia
Dhananjay Gupta
 
Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)
Arwa M. Amin
 
TREATMENT RESISTANT DEPRESSION
TREATMENT RESISTANT DEPRESSIONTREATMENT RESISTANT DEPRESSION
TREATMENT RESISTANT DEPRESSION
Subrata Naskar
 
Recent advances in the treatment of epilepsy
Recent advances in the treatment of epilepsyRecent advances in the treatment of epilepsy
Recent advances in the treatment of epilepsy
Dr. Mohit Kulmi
 
Transient Global Amnesia
Transient Global Amnesia Transient Global Amnesia
Transient Global Amnesia
Ade Wijaya
 
Neuropsychiatric Systemic Lupus Erythematosus
Neuropsychiatric Systemic Lupus Erythematosus Neuropsychiatric Systemic Lupus Erythematosus
Neuropsychiatric Systemic Lupus Erythematosus
Ade Wijaya
 
Reversible dementia
Reversible dementiaReversible dementia
Reversible dementia
Ahmed Ghany
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
Ruso Genebashvili
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
NeurologyKota
 
Antiepileptic in systemic disorder
Antiepileptic in  systemic disorderAntiepileptic in  systemic disorder
Antiepileptic in systemic disorder
NeurologyKota
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
suneelkk
 
Autoimmune Encephalitis
Autoimmune EncephalitisAutoimmune Encephalitis
Autoimmune Encephalitis
Neha Rai
 
Epileptic encephalopathies during infancy
Epileptic encephalopathies during infancyEpileptic encephalopathies during infancy
Epileptic encephalopathies during infancy
Dr. Arghya Deb
 
Epilepsy
EpilepsyEpilepsy
Autoimmune encephalitis in children
Autoimmune encephalitis in childrenAutoimmune encephalitis in children
Autoimmune encephalitis in children
Gajanan Yelme
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptx
Pramod Krishnan
 
Prognosis of schizophrenia
Prognosis of schizophreniaPrognosis of schizophrenia
Prognosis of schizophrenia
Karrar Husain
 

What's hot (20)

Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
 
Drug Resistant Epilepsy
Drug Resistant EpilepsyDrug Resistant Epilepsy
Drug Resistant Epilepsy
 
Dementia updates
Dementia  updates  Dementia  updates
Dementia updates
 
Approach to a case of Dementia
Approach to a case of Dementia Approach to a case of Dementia
Approach to a case of Dementia
 
Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)
 
TREATMENT RESISTANT DEPRESSION
TREATMENT RESISTANT DEPRESSIONTREATMENT RESISTANT DEPRESSION
TREATMENT RESISTANT DEPRESSION
 
Recent advances in the treatment of epilepsy
Recent advances in the treatment of epilepsyRecent advances in the treatment of epilepsy
Recent advances in the treatment of epilepsy
 
Transient Global Amnesia
Transient Global Amnesia Transient Global Amnesia
Transient Global Amnesia
 
Neuropsychiatric Systemic Lupus Erythematosus
Neuropsychiatric Systemic Lupus Erythematosus Neuropsychiatric Systemic Lupus Erythematosus
Neuropsychiatric Systemic Lupus Erythematosus
 
Reversible dementia
Reversible dementiaReversible dementia
Reversible dementia
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Antiepileptic in systemic disorder
Antiepileptic in  systemic disorderAntiepileptic in  systemic disorder
Antiepileptic in systemic disorder
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Autoimmune Encephalitis
Autoimmune EncephalitisAutoimmune Encephalitis
Autoimmune Encephalitis
 
Epileptic encephalopathies during infancy
Epileptic encephalopathies during infancyEpileptic encephalopathies during infancy
Epileptic encephalopathies during infancy
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Autoimmune encephalitis in children
Autoimmune encephalitis in childrenAutoimmune encephalitis in children
Autoimmune encephalitis in children
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptx
 
Prognosis of schizophrenia
Prognosis of schizophreniaPrognosis of schizophrenia
Prognosis of schizophrenia
 

Viewers also liked

Ad webinar diet and exercise to prevent cognitive decline
Ad webinar diet and exercise to prevent cognitive declineAd webinar diet and exercise to prevent cognitive decline
Ad webinar diet and exercise to prevent cognitive decline
wef
 
Prz
PrzPrz
Global Dementia Legacy Event: Raj Long, Senior Regulatory Officer
Global Dementia Legacy Event: Raj Long, Senior Regulatory OfficerGlobal Dementia Legacy Event: Raj Long, Senior Regulatory Officer
Global Dementia Legacy Event: Raj Long, Senior Regulatory Officer
Department of Health
 
Herts third sector mental health presentation final
Herts third sector mental health presentation finalHerts third sector mental health presentation final
Herts third sector mental health presentation final
Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol
 
European Chiropractor's Union - 2014 - Dublin
European Chiropractor's Union - 2014 - DublinEuropean Chiropractor's Union - 2014 - Dublin
European Chiropractor's Union - 2014 - Dublin
jpndresearch
 
Movers & Shakers: Health and Wellbeing for Older People
Movers & Shakers: Health and Wellbeing for Older PeopleMovers & Shakers: Health and Wellbeing for Older People
Movers & Shakers: Health and Wellbeing for Older People
University of Bath
 
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Department of Health
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2
ifa2012
 
Lighting and the Health and Wellbeing of Older People
Lighting and the Health and Wellbeing of Older PeopleLighting and the Health and Wellbeing of Older People
Lighting and the Health and Wellbeing of Older People
Institution of Lighting Professionals
 
Statistics - How Healthy is the Filipino
Statistics - How Healthy is the FilipinoStatistics - How Healthy is the Filipino
Statistics - How Healthy is the Filipino
AXAFailProofYourFuture
 
Dementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-saDementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-sa
Swapna Kishore
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disorders
Pramod Krishnan
 
OVERVIEW OF DEMENTIA
OVERVIEW OF DEMENTIAOVERVIEW OF DEMENTIA
OVERVIEW OF DEMENTIA
wef
 
Dementia powerpoint
Dementia powerpointDementia powerpoint
Dementia powerpoint
Bgross01
 

Viewers also liked (14)

Ad webinar diet and exercise to prevent cognitive decline
Ad webinar diet and exercise to prevent cognitive declineAd webinar diet and exercise to prevent cognitive decline
Ad webinar diet and exercise to prevent cognitive decline
 
Prz
PrzPrz
Prz
 
Global Dementia Legacy Event: Raj Long, Senior Regulatory Officer
Global Dementia Legacy Event: Raj Long, Senior Regulatory OfficerGlobal Dementia Legacy Event: Raj Long, Senior Regulatory Officer
Global Dementia Legacy Event: Raj Long, Senior Regulatory Officer
 
Herts third sector mental health presentation final
Herts third sector mental health presentation finalHerts third sector mental health presentation final
Herts third sector mental health presentation final
 
European Chiropractor's Union - 2014 - Dublin
European Chiropractor's Union - 2014 - DublinEuropean Chiropractor's Union - 2014 - Dublin
European Chiropractor's Union - 2014 - Dublin
 
Movers & Shakers: Health and Wellbeing for Older People
Movers & Shakers: Health and Wellbeing for Older PeopleMovers & Shakers: Health and Wellbeing for Older People
Movers & Shakers: Health and Wellbeing for Older People
 
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2
 
Lighting and the Health and Wellbeing of Older People
Lighting and the Health and Wellbeing of Older PeopleLighting and the Health and Wellbeing of Older People
Lighting and the Health and Wellbeing of Older People
 
Statistics - How Healthy is the Filipino
Statistics - How Healthy is the FilipinoStatistics - How Healthy is the Filipino
Statistics - How Healthy is the Filipino
 
Dementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-saDementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-sa
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disorders
 
OVERVIEW OF DEMENTIA
OVERVIEW OF DEMENTIAOVERVIEW OF DEMENTIA
OVERVIEW OF DEMENTIA
 
Dementia powerpoint
Dementia powerpointDementia powerpoint
Dementia powerpoint
 

Similar to Dementia - what can Public Health do to respond to the scope for Prevention? - Olga Cleary

Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
Abdikani12
 
Martin Prince
Martin PrinceMartin Prince
Martin Prince
alzscotslides
 
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Evangelos Fragkoulis
 
Inequalities presentation SQAS Preston away day October 2018
Inequalities presentation SQAS Preston away day October 2018Inequalities presentation SQAS Preston away day October 2018
Inequalities presentation SQAS Preston away day October 2018
PHEScreening
 
Inequalities presentation preston away day october 2018
Inequalities presentation preston away day october 2018Inequalities presentation preston away day october 2018
Inequalities presentation preston away day october 2018
PHEScreening
 
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCCPatricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
Investnet
 
Vision health an integral part of public health in nigeria
Vision health an integral part of public health in nigeriaVision health an integral part of public health in nigeria
Vision health an integral part of public health in nigeria
Chibuzor Emereole
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’
drsanjaymaitra
 
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO   OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
SEJOJO PHAAROE
 
Overview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in EnglandOverview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in England
Dr Justin Varney
 
Epidemiology of diabetic retinopathy
Epidemiology of diabetic retinopathyEpidemiology of diabetic retinopathy
Epidemiology of diabetic retinopathy
DINESH and SONALEE
 
Critical Review of the current Policies, Strategies and Programs of Preventiv...
Critical Review of the current Policies, Strategies and Programs of Preventiv...Critical Review of the current Policies, Strategies and Programs of Preventiv...
Critical Review of the current Policies, Strategies and Programs of Preventiv...
Mohammad Aslam Shaiekh
 
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
anne spencer
 
Integrating technology into the treatment of mental health and addictive diso...
Integrating technology into the treatment of mental health and addictive diso...Integrating technology into the treatment of mental health and addictive diso...
Integrating technology into the treatment of mental health and addictive diso...
Hunter Institute of Mental Health
 
Session 2: Carol Brayne
Session 2: Carol Brayne Session 2: Carol Brayne
Session 2: Carol Brayne
The Humanitarian Centre
 
Measuring the patient’s perspective of the benefits of diabetes interventions
Measuring the patient’s perspective of the benefits of diabetes interventionsMeasuring the patient’s perspective of the benefits of diabetes interventions
Measuring the patient’s perspective of the benefits of diabetes interventions
Keith Meadows
 
Igor f. dubrovnik k
Igor f. dubrovnik kIgor f. dubrovnik k
Igor f. dubrovnik k
filipcic555
 
Prevention of mortality and morbidity in acute and chronic psychiatric patients
Prevention of mortality and morbidity in acute and chronic psychiatric patientsPrevention of mortality and morbidity in acute and chronic psychiatric patients
Prevention of mortality and morbidity in acute and chronic psychiatric patients
filipcic555
 
Ivoclar presentation 115
Ivoclar presentation 115Ivoclar presentation 115
Ivoclar presentation 115
Ivoclar06
 
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
Anticholinergic Drugs And Risk Of Dementia  Case-Control StudyAnticholinergic Drugs And Risk Of Dementia  Case-Control Study
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
Sandra Long
 

Similar to Dementia - what can Public Health do to respond to the scope for Prevention? - Olga Cleary (20)

Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Martin Prince
Martin PrinceMartin Prince
Martin Prince
 
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
 
Inequalities presentation SQAS Preston away day October 2018
Inequalities presentation SQAS Preston away day October 2018Inequalities presentation SQAS Preston away day October 2018
Inequalities presentation SQAS Preston away day October 2018
 
Inequalities presentation preston away day october 2018
Inequalities presentation preston away day october 2018Inequalities presentation preston away day october 2018
Inequalities presentation preston away day october 2018
 
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCCPatricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
Patricia Leahy Warren, Senior Lecturer School of Nursing and Midwifery, UCC
 
Vision health an integral part of public health in nigeria
Vision health an integral part of public health in nigeriaVision health an integral part of public health in nigeria
Vision health an integral part of public health in nigeria
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’
 
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO   OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
 
Overview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in EnglandOverview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in England
 
Epidemiology of diabetic retinopathy
Epidemiology of diabetic retinopathyEpidemiology of diabetic retinopathy
Epidemiology of diabetic retinopathy
 
Critical Review of the current Policies, Strategies and Programs of Preventiv...
Critical Review of the current Policies, Strategies and Programs of Preventiv...Critical Review of the current Policies, Strategies and Programs of Preventiv...
Critical Review of the current Policies, Strategies and Programs of Preventiv...
 
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
 
Integrating technology into the treatment of mental health and addictive diso...
Integrating technology into the treatment of mental health and addictive diso...Integrating technology into the treatment of mental health and addictive diso...
Integrating technology into the treatment of mental health and addictive diso...
 
Session 2: Carol Brayne
Session 2: Carol Brayne Session 2: Carol Brayne
Session 2: Carol Brayne
 
Measuring the patient’s perspective of the benefits of diabetes interventions
Measuring the patient’s perspective of the benefits of diabetes interventionsMeasuring the patient’s perspective of the benefits of diabetes interventions
Measuring the patient’s perspective of the benefits of diabetes interventions
 
Igor f. dubrovnik k
Igor f. dubrovnik kIgor f. dubrovnik k
Igor f. dubrovnik k
 
Prevention of mortality and morbidity in acute and chronic psychiatric patients
Prevention of mortality and morbidity in acute and chronic psychiatric patientsPrevention of mortality and morbidity in acute and chronic psychiatric patients
Prevention of mortality and morbidity in acute and chronic psychiatric patients
 
Ivoclar presentation 115
Ivoclar presentation 115Ivoclar presentation 115
Ivoclar presentation 115
 
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
Anticholinergic Drugs And Risk Of Dementia  Case-Control StudyAnticholinergic Drugs And Risk Of Dementia  Case-Control Study
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
 

More from Institute of Public Health in Ireland

Thomas T Prohaska
Thomas T ProhaskaThomas T Prohaska
Theo van Tilberg
Theo van TilbergTheo van Tilberg
Christina Victor
Christina VictorChristina Victor
James Lubben
James LubbenJames Lubben
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Institute of Public Health in Ireland
 
Prof. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College DublinProf. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College Dublin
Institute of Public Health in Ireland
 
Vanda Cummins, Health Service Executive
Vanda Cummins, Health Service ExecutiveVanda Cummins, Health Service Executive
Vanda Cummins, Health Service Executive
Institute of Public Health in Ireland
 
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Institute of Public Health in Ireland
 
Dr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General PractitionersDr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General Practitioners
Institute of Public Health in Ireland
 
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae HospitalAnne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Institute of Public Health in Ireland
 
Dr Andrew O'Regan
Dr Andrew O'ReganDr Andrew O'Regan
Alan Donnelly
Alan DonnellyAlan Donnelly
Seamus Nugent
Seamus NugentSeamus Nugent
Michael Mc Corry
Michael Mc CorryMichael Mc Corry
Andrew Boyd
Andrew BoydAndrew Boyd
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern IrelandProf. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Institute of Public Health in Ireland
 
Dr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to childrenDr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to children
Institute of Public Health in Ireland
 
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of HealthDr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Institute of Public Health in Ireland
 
Rita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & SkillsRita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & Skills
Institute of Public Health in Ireland
 
Paul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education CentrePaul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education Centre
Institute of Public Health in Ireland
 

More from Institute of Public Health in Ireland (20)

Thomas T Prohaska
Thomas T ProhaskaThomas T Prohaska
Thomas T Prohaska
 
Theo van Tilberg
Theo van TilbergTheo van Tilberg
Theo van Tilberg
 
Christina Victor
Christina VictorChristina Victor
Christina Victor
 
James Lubben
James LubbenJames Lubben
James Lubben
 
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
 
Prof. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College DublinProf. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College Dublin
 
Vanda Cummins, Health Service Executive
Vanda Cummins, Health Service ExecutiveVanda Cummins, Health Service Executive
Vanda Cummins, Health Service Executive
 
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
 
Dr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General PractitionersDr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General Practitioners
 
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae HospitalAnne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
 
Dr Andrew O'Regan
Dr Andrew O'ReganDr Andrew O'Regan
Dr Andrew O'Regan
 
Alan Donnelly
Alan DonnellyAlan Donnelly
Alan Donnelly
 
Seamus Nugent
Seamus NugentSeamus Nugent
Seamus Nugent
 
Michael Mc Corry
Michael Mc CorryMichael Mc Corry
Michael Mc Corry
 
Andrew Boyd
Andrew BoydAndrew Boyd
Andrew Boyd
 
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern IrelandProf. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
 
Dr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to childrenDr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to children
 
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of HealthDr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
 
Rita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & SkillsRita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & Skills
 
Paul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education CentrePaul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education Centre
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 

Dementia - what can Public Health do to respond to the scope for Prevention? - Olga Cleary

  • 1. Dementia –what role for prevention? Institute of Public Health Alzheimer’s Society of Ireland Olga Cleary PhD IPH Open Conference 14th October 2014
  • 2. Overview • Prevalence • Impact • Evidence • Terminology • Dementia protective and risk factors • Population attributable risk for modifiable factors in Ireland • Population approach to dementia prevention • Process – embedding dementia prevention in research, policy and practice Why? What? How?
  • 3. Emergence of Neurodegenerative disorders Epidemiological transition is underway as a result of demographic ageing, characterised by an increase in neurodegenerative disorders which will gradually come to replace the current burden of chronic degenerative disorders as the primary cause of morbidity and mortality in the 21st century!
  • 4. Dementia prevalence estimates • Worldwide - 44 million living with dementia (ADI, 2013) • Western Europe - 7 million living with dementia in 2010 (Prince, 2009) • Ireland – 47,744 living with dementia in 2011 (Cahill, and Pierce 2013). • Expected to double every 20 years • By 2031 (if current assumptions hold) estimated to be 90,000 people living with dementia in Ireland
  • 5. Impact Care setting Proportion of people with dementia Community 63% Residential Long-stay Care 34% Acute Care 2% Psychiatric Care 1% All 100% Connolly et al, 2014 • €40,500 - average cost per person with dementia per annum • €1.69 billion in 2010 Lowin et al, 2001; Trepel 2012 • At the individual level, the economic burden of dementia ranks higher than stroke, heart disease and cancer combined - allocated resources substantially lower than each of these individual disease groups
  • 6. Question..? Resource allocation…………. Management Treatment Diagnosis Prevention
  • 8. Alcohol Physical inactivity Coron. heart dis. Chron. kidney disease Diabetes Cholesterol Smoking Midlife obesity High cognitive activity Depressed mood Healthy diet Midlife hypertension In-MINDD dementia risk model
  • 9. Modelling modifiable dementia risk in Ireland Methodology - Lancet Neurology Barnes and Yaffe (2011) and Norton et al (2014) Systematic reviews & meta-analyses – potentially modifiable factors associated with increase in Alzheimer’s Disease and cognitive decline (Daviglus et al 2010; McGuiness et al 2009; Profenno 2010) 7 Factors with most consistent evidence: • Diabetes Mellitus • Current smoking • Depression • Low educational attainment • Physical inactivity • Obesity • Hypertension • Poor diet (high sat fat/low veg) Calculated PAR based on RRs from Cochrane reviews/meta-analyses - Assuming causal relationship between risk factor and disease, PAR is number of cases of a disease in a population attributable to the risk factor. Irish prevalence estimates taken from Cahill and Pierce (2013) applying EuroCoDe dementia prevalence to 2011 census data
  • 10. Population attributable risk and estimated number of attributable cases in Ireland 2011. Risk factors TILDA weighted prevalence % Relative Risk 95% CI’s PAR 95% CI’s Number of attributable cases in 2011 (47,744) 95% CIs Low education 38% 1.59 (1.35-1.86) 18.3% (11.7-24.6) 8,737 (5,586-11,745) Obesity 34% 1.6 (1.34-1.92) 16.9% (10.4-23.8) 8,069 (4,965-11,363) High Blood 32% 1.61 (1.16-2.24) 16.5% (4.9-28.7) 7,878 (2,339-13,703) Pressure Physical Inactivity 32% 1.82 (1.19-2.78) 20.8% (5.7-36.3) 9,930 (2,721-17,331) Smoking 20% 1.59 (1.15-2.2) 10.6% (2.9-19.3) 5,060 (1,385-9,215) Diabetes 8% 1.46 (1.2-1.77) 3.5% (1.6-5.8) 1,671 (764-2,769) Depression 5% 1.65 (1.42-1.92) 3.1% (2.1-4.4) 1,480 (1,003-2,101) COMBINED 62.5% (33.6-81.0) 29,840 (16,042-38,673)
  • 11. Strengths and limitations • Estimates based on best available evidence • PAR estimates assume a causal relationship between risk factor and dementia outcome, however dementia is multi-factorial and it is not known if removal/reduction of single risk factors will lower incidence • Relative risks while robust, are not based on Irish data • Risk relations are taken at particular ages and it was not possible to model the dynamic interplay of risk factors over the lifecycle. • Have not adjusted for the non-independence of risk factors • May be other important factors influencing risk not accounted for in analyses. • Community dwelling population in TILDA (excludes institutionalised and dementia diagnosed)
  • 12. Implications of study findings • Reductions in prevalence of key modifiable risk factors for dementia is likely to lead to a reduction in the onset and prevalence of dementia at a population level in Ireland. • Estimated combined PAR for Ireland (independent) = 62.5% • Pooled methods, accounting for non-independence of the risk factors examined, estimated a much more conservative effect (Norton, 2014). • Estimated combined PAR for Europe (independent) = 52.7% • Estimated pooled combined PAR for Europe (non-independence) = 30.6% • True effect in modifying risk factors remains unknown and we require further studies to fully investigate this, but it is likely to lie in the magnitude of 30-60% in Ireland. • This equates to 14,243 – 28,468 people living with dementia at any one time in Ireland. • €576,841,500 per annum cost of dementia patients
  • 13. Developing a population health approach to dementia prevention • Need to mitigate burden of dementia • Moving from: • Treatment and management to prevention • Clinical concepts to public health • Individual focus to population health focus (WHO, 2012) • Research to policy and practice Older people with better vascular health, who have been more physically, mentally and socially active, whose diet is lower in saturated fats and higher in vegetable and fruit consumption, who don’t smoke and who drink alcohol in moderation are significantly less likely on average to develop dementia.
  • 14. Development of a public health approach to dementia prevention that is strategic, evidence-based and comprehensive (McDaid and McAvoy, 2012 - National Dementia Strategy submission) • Potential for public health interventions • Synergies in prevention • Embed dementia prevention in policy and practice • Enhance current DoH and HSE strategies and programmes • Afford priority to counteracting risk factors for CVD • Appropriate intervention for CVD risk factors and preventative health practices in primary care • Concept of brain health emerging as an important paradigm on the neuroscience and public health agenda • Social patterning and early years intervention
  • 15. Thank You! Contact: olga.cleary@publichealth.ie Acknowledgements: Helen McAvoy and Owen Metcalf (Institute of Public Health) Margaret Crean, Emer Begley and Grainne McGettrick (Alzheimer’s Society of Ireland) TILDA team

Editor's Notes

  1. Irish figures based on best available estimates – applied to CSO figures. We do not have population prevalence rates
  2. Outcomes for people with dementia are poor, with high mortality, increased risk of admission to long-stay care and increased length of stay in hospital. Excess length of hospital stays are significant drivers of costs. Cost of dementia study attempted to measure, valuate and apply per unit costs for primary, community and hospital based care as well as costs per resident in long-stay care. Not a simple exercise and provides best estimated costs. Need for improved resource costs for healthcare and requires further sensitivity analyses. Bust costs are broadly in line with those found in other studies.
  3. The prevalence estimates and costs highlight that significant decisions need to be made regarding the allocation and efficient use of resources both now and into the future… Promising news that prevention works – there are factors that both promote and reduce dementia risk Balancing the treatment/management of dementia with prevention strategies – knowing who to target and knowing when to target them.. Issues of inequality in dementia – it is socially patterned Leading scientists have backed calls for a fresh policy approach to combat dementia in the UK by focusing on reducing risk factors and promoting brain health throughout people’s lives. They said that “a substantial proportion of dementia might be delayed or averted if modifiable risk factors are effectively addressed.” The UK Health Forum and Public Health England launched a consensus statement on 20 May signed by 59 experts and organisations, including practitioners and researchers in dementia, public health, and non-communicable disease (NCD) prevention. It said that evidence was now “sufficient” to justify action and further research on dementia risk reduction by “reducing the modifiable risk factors and improving the recognised protective factors,” the statement said. The experts described a “compelling” case for dementia risk reduction to be incorporated into health policies that are designed to tackle NCDs, to make better use of current efforts and resources. … NICE Guidelines Systematic Reviews
  4. How we conceptualise dementia prevention is very important – need a framework to operate in – and clear terms and definitions – however to date terms have been ‘confused’ and used interchangeably with poorly defined concepts. Terms tend to develop organically and are applied in the literature without much consideration – leads to a diffuse literature which is unhelpful when examining the evidence base. How each term relates to each other is also unclear – we need more conceptual work on this to provide a clear framework within which to operate in public health. I use the term ‘Dementia prevention’ to encompass all of these concepts and highlight the importance of the concept of Brain Health which is a positive term useful for health promotion and public health which encapsulates lifecourse influences on cognitive development and maintaining a healthy brain.
  5. Protective factors: High cognitive activity, Health diet, Low to moderate alcohol consumption  Risk factors: Depressed mood, Midlife hypertension, Midlife obesity, Smoking, High cholesterol, Physical inactivity. Having the following three conditions also places people at higher risk of developing dementia: Diabetes, Chronic Kidney disease and Cardiovascular disease, hence the need for lifestyle changes as part of primary and secondary prevention of these three conditions. 
  6. AD is most common cause of dementia 60-80% of all cases. Delaying symptom onset by 1 year could reduce prevalence by 9 million cases worldwide by 2040. Calculating population attributable risks 7 risk factors Number of AD cases that could potentially be prevented
  7. Self reported doctor diagnosis of risk factors in TILDA Combined estimate is high due to lack of communality analysis on risk factors most recent study applied pooled risk factors to account for the pooled effect of risk factors – concluded that around 30% of cases in the UK are due to the modifiable risk factors accounted for here (independent analysis (before pooling was estimated to be 52%). Likely that the true effect is lower than estimated here.
  8. Estimates based on best available evidence PAR estimates assume a causal relationship between risk factor and dementia outcome, however dementia is multi-factorial and it is not known if removal/reduction of single risk factors will lower incidence – evidence indicates that increased risk increases incidence – however the corollary has not yet been shown – that decreased risk decreases incidence – research gap.
  9. The need to mitigate the associated burden of dementia moves the onus firmly into the public health arena and there is now an increasing awareness of the need to move the science of dementia prevention into practice. To this end, the World Health Organization has recommended the development of a public health approach to dementia prevention (World Health Organization, 2012) and the Alzheimer’s Association and Centers for Disease Control and Prevention in the U.S. have recently developed a public health road map for dementia prevention (2013) rooted within a population health approach. In its submission to the Department of Health on A National Strategy on Dementia, the IPH advocated for a development of a public health approach to dementia prevention that is strategic, evidence-based, comprehensive and patient-centred (McDaid and McAvoy, 2012). Older people with better vascular health, who have been more physically, mentally and socially active, whose diet is lower in saturated fats and higher in vegetable and fruit consumption, who don’t smoke and who drink alcohol in moderation are significantly less likely on average to develop dementia. These modifiable risk factors are often conceptualised as delaying factors which postpone the onset of dementia rather than definitively preventing the condition (Gatz et al., 2006). There is now an opportunity to develop and implement strategies to reduce dementia risk in Ireland and reduce the burden of dementia in later life. It is acknowledged that early onset dementia may occur in certain population sub-groups.
  10. Public health interventions potential to reduce prevalence and delay onset Synergies in prevention Afford priority to counteracting risk factors for CVD including diabetes, hypertension, obesity, smoking and physical activity Enhance current DoH and HSE strategies and programmes Appropriate intervention for CVD risk factors in primary care Embedding preventative health practices into primary care services essential to support the prevention of dementia and several chronic conditions in later life. Concept of brain health emerging as an important paradigm on the neuroscience and public health agenda. Social patterning and early years intervention